Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONFERENCE)
March 02 2021 - 8:05AM
Organovo Holdings, Inc. (Nasdaq: ONVO), today announced it will be
featured as a presenting company at the H.C. Wainwright Global Life
Sciences Conference. The conference is being held on March
9-10, 2021 virtually.
Keith Murphy, Executive Chairman of Organovo, will provide an
overview of the Company's business during the presentation.
A webcast of Organovo’s presentation will be accessible through
the Investors & Media section of the company’s website at
www.organovo.com. A replay of the webcast will be available on
Organovo’s website for 90 days following the conference.
About Organovo
Organovo is an early-stage biotechnology company that is
developing and utilizing highly customized 3D human tissues as
dynamic models of healthy and diseased human biology for drug
development. The company’s proprietary technology is being used to
build functional 3D human tissues that mimic key aspects of native
human tissue composition, architecture, function and disease.
Organovo’s advances include cell type-specific compartments,
prevalent intercellular tight junctions, and the formation of
microvascular structures. Management believes these attributes can
enable critical complex, multicellular disease models that can be
used to develop clinically effective drugs for selected therapeutic
areas.
Forward Looking Statements
Any statements contained in this press release that do not
describe historical facts constitute forward-looking statements as
that term is defined in the Private Securities Litigation Reform
Act of 1995. Any forward-looking statements contained herein are
based on current expectations, but are subject to a number of risks
and uncertainties. These risks and uncertainties and other factors
are identified and described in more detail in the Company’s
filings with the SEC, including its Quarterly Report on Form
10-Q filed with the SEC on February 8, 2021. You
should not place undue reliance on these forward-looking
statements, which speak only as of the date that they were made.
These cautionary statements should be considered with any written
or oral forward-looking statements that the Company may issue in
the future. Except as required by applicable law, including the
securities laws of the United States, the Company does not
intend to update any of the forward-looking statements to conform
these statements to reflect actual results, later events or
circumstances or to reflect the occurrence of unanticipated
events.
Investor Contact
Amato and Partners, LLCInvestor Relations
Counseladmin@amatoandpartners.com
Organovo (NASDAQ:ONVO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Organovo (NASDAQ:ONVO)
Historical Stock Chart
From Apr 2023 to Apr 2024